Showing results (161-170 of 291) with videos related to

Sort By:
Pageof 30
Nature Chemical Biology|July 19, 2011
Serendipitous alkylation of a Plk1 ligand uncovers a new binding channelFa Liu, Jung-Eun Park, Wen-Jian Qian, et al.
Chemistry & Biology|October 15, 2013
Peptide-based inhibitors of Plk1 polo-box domain containing mono-anionic phosphothreonine esters and their pivaloyloxymethyl prodrugsWen-Jian Qian, Jung-Eun Park, Dan Lim, et al.
Chembiochem : a European Journal of Chemical Biology|May 10, 2012
Peptoid-Peptide hybrid ligands targeting the polo box domain of polo-like kinase 1Fa Liu, Jung-Eun Park, Wen-Jian Qian, et al.
Molecular Cell|June 7, 2002
Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2Jiejin Li, Brandi L Williams, Lesley F Haire, et al.
Shock (Augusta, Ga.)|May 27, 2015
Kinetics and Role of Plasma Matrix Metalloproteinase-9 Expression in Acute Lung Injury and the Acute Respiratory Distress SyndromeAlbert T Hsu, Christopher D Barrett, George M DeBusk, et al.
Nature Cell Biology|June 24, 2008
TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewalXaralabos Varelas, Rui Sakuma, Payman Samavarchi-Tehrani, et al.
Current Biology : CB|June 21, 2005
Polo-like kinase 1 creates the tension-sensing 3F3/2 phosphoepitope and modulates the association of spindle-checkpoint proteins at kinetochoresLeena J Ahonen, Marko J Kallio, John R Daum, et al.
ACS Chemical Biology|February 2, 2012
Identification of high affinity polo-like kinase 1 (Plk1) polo-box domain binding peptides using oxime-based diversificationFa Liu, Jung-Eun Park, Wen-Jian Qian, et al.
The Journal of Trauma and Acute Care Surgery|November 24, 2020
Plasmin thrombelastography rapidly identifies trauma patients at risk for massive transfusion, mortality, and hyperfibrinolysis: A diagnostic tool to resolve an international debate on tranexamic acid?Christopher D Barrett, Hunter B Moore, Navin Vigneshwar, et al.
Cancer Research|April 22, 2010
Impaired SHP2-mediated extracellular signal-regulated kinase activation contributes to gefitinib sensitivity of lung cancer cells with epidermal growth factor receptor-activating mutationsMatthew J Lazzara, Keara Lane, Richard Chan, et al.
Pageof 30